13F filer · CIK 1167557 ↗

AQR Capital

You are looking at Q4 2017. See the latest, Q2 2026 →

Reported value

$95.29B

+14% on the quarter before

Positions

2,215

124 new · 143 sold out

Top 10

10.6%

of the value

Est. gain

+$4.69B

on stocks held all quarter

Est. return

+6.3%

on those stocks since Q3 2017

Filed

Feb 14, 2018

On SEC EDGAR ↗

Positions as of Dec 31, 2017, from AQR Capital's 13F filing with the SEC. A 13F lists a manager's US-listed stocks and options at a quarter end and is filed up to 45 days later, so the fund may hold something else today. It leaves out short positions, cash and holdings outside the US.

Portfolio at a glance

  • New
  • Added
  • Cut
  • Same
  • Options

The 24 largest positions, 21% of the reported value, each sized by its share, colored by what the fund did with it since Q3 2017. Striped tiles are options.

Apple1.4%Microsoft1.3%Meta1.3%
Lyondellbasell Industries N1.1%
Boeing Co1.0%
Gilead Sciences Inc0.9%
Alphabet0.9%Western Digital0.9%
Ebay Inc0.9%
Micron0.8%Oracle0.8%
Anthem Inc0.8%
Wal-Mart Stores Inc0.8%
Johnson & Johnson0.8%
Allstate Corp0.8%
Jpmorgan Chase & Co0.8%
Amazon0.8%Intel0.8%
Pfizer Inc0.7%
Alibaba0.7%
Humana Inc0.7%
TSMC0.7%Walt Disney Company (The)0.7%
Best Buy Inc0.7%

Largest buys

Since Q3 2017, by estimated size: the change in shares at the quarter-end price, since a 13F gives no trade prices. Percentages are the position's share of the portfolio, before and after.

  1. Meta~$510.3MAdded · 0.8% → 1.3%+2,892,074 shares
  2. Oracle~$437.6MAdded · 0.4% → 0.8%+9,255,944 shares
  3. Western Digital~$409.1MAdded · 0.6% → 0.9%+5,143,651 shares
  4. Lyondellbasell Industries N~$295.5MAdded · 0.9% → 1.1%+2,678,212 shares
  5. Celgene Corp~$248.2MAdded · 0.3% → 0.5%+2,378,345 shares
  6. IQVIA~$237.8MNew · 0.0% → 0.2%+2,428,988 shares
  7. Amazon~$222.4MAdded · 0.5% → 0.8%+190,208 shares
  8. Nvidia~$205.3MAdded · 0.2% → 0.4%+1,061,007 shares
  9. Tyson Foods Inc~$197.5MAdded · 0.3% → 0.5%+2,435,964 shares
  10. Mckesson Corp~$184.4MAdded · 0.5% → 0.6%+1,182,353 shares

Largest sells

Since Q3 2017, by estimated size: the change in shares at the quarter-end price, since a 13F gives no trade prices. Percentages are the position's share of the portfolio, before and after.

  1. Aetna Inc New~$278.3MCut · 0.4% → 0.1%−1,542,661 shares
  2. Regions Finl Corp New~$188.1MCut · 0.3% → 0.1%−10,886,635 shares
  3. General Mtrs Co~$181.6MCut · 0.8% → 0.5%−4,429,880 shares
  4. Pg&E Corp~$176.4MCut · 0.4% → 0.1%−3,935,805 shares
  5. Suntrust Bks Inc~$166.6MCut · 0.5% → 0.3%−2,579,327 shares
  6. Intel~$159.9MCut · 0.9% → 0.8%−3,463,958 shares
  7. Wal-Mart Stores Inc~$158.6MCut · 0.9% → 0.8%−1,605,973 shares
  8. PSEG~$148.4MCut · 0.5% → 0.4%−2,880,983 shares
  9. Ingersoll-Rand Plc~$131.3MCut · 0.3% → 0.1%−1,472,155 shares
  10. Hewlett Packard Enterprise~$124.4MCut · 0.3% → 0.1%−8,664,210 shares

Holdings

As of Dec 31, 2017. Changes are in shares against Sep 30, 2017, so a price move alone never reads as a buy or a sale.

Positions, sorted by share of the portfolio
HoldingValue
AppleCOM · shares +8.4% · price +9.8%1.4%$1.29B+$106.5M
MicrosoftCOM · shares +8.6% · price +14.8%1.3%$1.24B+$148.0M
MetaCL A · shares +72% · price +3.3%1.3%$1.22B+$22.5M
Lyondellbasell Industries NSHS - A - · shares +37% · price +11.2%1.1%$1.09B+$79.9M
Boeing CoCOM · shares +25% · price +16.0%0.97%$921.1M+$101.7M
Gilead Sciences IncCOM · shares +4.3% · price −11.6%0.95%$905.0M−$113.7M
AlphabetCAP STK CL A · shares +26% · price +8.2%0.94%$893.1M+$53.6M
Western DigitalCOM · shares +93% · price −8.0%0.89%$850.4M−$38.1M
Ebay IncCOM · shares +18% · price −1.9%0.88%$837.9M−$13.5M
MicronCOM · shares +16% · price +4.6%0.84%$800.5M+$30.2M
OracleCOM · shares +124% · price −2.6%0.83%$789.2M−$9.4M
Anthem IncCOM · shares +7.8% · price +18.5%0.82%$777.4M+$112.6M
Wal-Mart Stores IncCOM · shares −17% · price +25.6%0.82%$777.1M+$158.5M
Johnson & JohnsonCOM · shares +9.5% · price +7.5%0.79%$755.0M+$47.9M
Allstate CorpCOM · shares +1.6% · price +13.9%0.78%$746.4M+$89.8M
Jpmorgan Chase & CoCOM · shares −2.2% · price +12.0%0.78%$739.0M+$79.0M
AmazonCOM · shares +44% · price +21.6%0.76%$728.3M+$90.0M
IntelCOM · shares −18% · price +21.2%0.75%$718.9M+$125.8M
Pfizer IncCOM · shares −8.5% · price +1.5%0.73%$691.4M+$9.9M
AlibabaSPONSORED ADS · shares −0.7% · price −0.2%0.70%$671.6M−$1.1M
Humana IncCOM · shares +14% · price +1.8%0.69%$653.0M+$10.2M
TSMCSPONSORED ADR · shares +11% · price +5.6%0.67%$636.6M+$30.3M
Walt Disney Company (The)COM DISNEY · shares −5.1% · price +9.1%0.67%$634.9M+$52.8M
Best Buy IncCOM · shares +4.6% · price +20.2%0.67%$634.8M+$102.0M
Amgen IncCOM · shares +24% · price −6.7%0.66%$633.3M−$36.7M
Total · 2,215 positions100%$95.29B+$4.69B
The filing on SEC EDGAR ↗

Price is a stock's reported value over its shares at the quarter end. The estimated gain is the shares held at both quarter ends times the change in that price: shares bought or sold during the quarter add nothing, options are left out, and a stock split is read into the earlier share count and price.

What made money

From Q3 2017 to Q4 2017: 2,091 stocks held throughout, up $4.69B (+6.3%).

  1. Wal-Mart Stores Inc+$158.5M+26%
  2. Microsoft+$148.0M+15%
  3. Intel+$125.8M+21%
  4. Anthem Inc+$112.6M+19%
  5. Apple+$106.5M+10%
  6. Western Digital−$38.1M−8%
  7. Edison Intl−$53.3M−18%
  8. Merck & Co Inc−$76.2M−12%
  9. Celgene Corp−$82.9M−28%
  10. Gilead Sciences Inc−$113.7M−12%

Estimated as in the holdings table: shares held at both quarter ends times the change in price; options left out, 3 splits read into the share counts.

Reported value by quarter

The total value of each quarter's 13F at that quarter end. It moves with prices as well as with buying and selling. Pick a quarter to see what the fund held then.

$400.00B$200.00B$0
Q1 2016Q2 2026
Every quarter's filing
Each quarter's 13F filing, newest first
QuarterReported valueFiling
Q2 2026$286.85B+31%SEC ↗
Q1 2026$218.37B+15%SEC ↗
Q4 2025$190.63B+22%SEC ↗
Q3 2025$156.00B+29%SEC ↗
Q2 2025$120.88B+25%SEC ↗
Q1 2025$97.07B+25%SEC ↗
Q4 2024$77.63B+7%SEC ↗
Q3 2024$72.44B+11%SEC ↗
Q2 2024$65.24B+11%SEC ↗
Q1 2024$58.73B+11%SEC ↗
Q4 2023$53.13B+10%SEC ↗
Q3 2023$48.43B+3%SEC ↗
Q2 2023$47.05B+3%SEC ↗
Q1 2023$45.56B+4%SEC ↗
Q4 2022$43.89B+7%SEC ↗
Q3 2022$41.02B−7%SEC ↗
Q2 2022$44.25B−16%SEC ↗
Q1 2022$52.69B−4%SEC ↗
Q4 2021$55.17B+2%SEC ↗
Q3 2021$53.94B−7%SEC ↗
Q2 2021$57.80B−5%SEC ↗
Q1 2021$61.14B+8%SEC ↗
Q4 2020$56.41B−5%SEC ↗
Q3 2020$59.16B−4%SEC ↗
Q2 2020$61.82B+4%SEC ↗
Q1 2020$59.45B−32%SEC ↗
Q4 2019$87.96B+4%SEC ↗
Q3 2019$84.91B−5%SEC ↗
Q2 2019$89.62B−5%SEC ↗
Q1 2019$94.26B+9%SEC ↗
Q4 2018$86.30B−17%SEC ↗
Q3 2018$104.52B+5%SEC ↗
Q2 2018$99.28B+7%SEC ↗
Q1 2018$92.73B−3%SEC ↗
Q4 2017$95.29B+14%SEC ↗
Q3 2017$83.80B+11%SEC ↗
Q2 2017$75.57B+0%SEC ↗
Q1 2017$75.24B+4%SEC ↗
Q4 2016$72.48B+11%SEC ↗
Q3 2016$65.33B+15%SEC ↗
Q2 2016$56.67B+2%SEC ↗
Q1 2016$55.59BSEC ↗

Get the newsletter

The day's AI and market news, in your inbox every weekday.